SHARE...
Surgery – Biopsies Cause Metastasis – New Study finds
Questioning Chemotherapy – Dr. Ralph Moss
New Findings Support Warburg Theory Of Cancer
Kickbacks for Drugs Are Dangerous
Influence of Big Pharma on social media
Dr. Michelakis May 2012 paper published in Oncogene
Common Chemotherapy Drugs and Side Effects
Chemotherapy Does Not Work – Dr. Ralph Moss
Cancer Research – A Super Fraud?
By Jon Barron, “Chemotherapy: An Interesting Option”
British Journal of Cancer DCA Mini Review
Breast Cancer Awareness Month Misleads Women
1 in 3 patients harmed during hospital stay
+ Author Affiliations
Link: https://dmd.aspetjournals.org/content/40/2/232.abstract
Abstract
Maleylacetoacetate isomerase, also known as glutathione transferase 1 (GSTZ1), catalyzes the penultimate step of tyrosine catabolism and metabolizes a number of -halocarboxylic acids, including dichloroacetic acid (DCA), a recently discovered investigational treatment for solid tumors and lactic acidosis. DCA pharmacotoxicology has shown age-related changes, but there is no data on GSTZ1 ontogeny in humans. Using human livers from donors between 10 weeks gestation and 74 years old, we looked at the cytosolic GSTZ1 developmental expression pattern and the effect of haplotype on GSTZ1 activity in this study. In fetal livers, there was very little GSTZ1 expression (2 pmol of GSTZ1/mg cytosol). After birth, the expression increased in an age-dependent manner until 7 years old. After that, GSTZ1 was maintained at steady but variable levels until the age of 74 (median, 20.0 pmol/mg cytosol; range, 4.8-47.3 pmol/mg cytosol). With DCA, GSTZ1 activity was highly correlated with haplotype and expression level. At a specific level of expression, samples homozygous or heterozygous for GSTZ1A showed about three times more DCA dechlorinating activity than samples bearing other alleles. The correlations (r2) between activity and expression for GSTZ1A carriers (n = 11) and noncarriers (n = 61) were 0.90 and 0.68, respectively. In addition to the cytosol, mitochondria also express GSTZ1. Similar changes were seen in the mitochondrial fraction due to the GSTZ1A genotype, which increased DCA activity. In conclusion, we reveal that GSTZ1 protein expression during human liver development has a neonatal onset and rises with age. GSTZ1 activity with DCA was altered by haplotype but not protein expression.
Footnotes
National Institutes of Health National Institute of Environmental Health Sciences [Grants ES007355, ES014617] (to P.W.S.) and National Institutes of Health National Institute of General Medical Sciences [Grant GM081344] both provided funding in support of this research (to R.N.H.).
Information about the article, its release date, and its citations can be found at https://dmd.aspetjournals.org.
doi:https://dx.doi.org/10.1124/dmd.111.041533.
↵ The article’s online version may be found at https://dmd.aspetjournals.org) contains supplemental material.
ABBREVIATIONS:
GSTZ1
1 glutathione transferase
DCA
dichloroacetate
MAAI
isomerase for maleylacetoacetate
SNP
single nucleotide variation
LOQ
a measure of quantity.
Awarded on July 5, 2011.
October 25, 2011, accepted
The American Society for Pharmacology and Experimental Therapeutics is the copyright holder as of 2012.
MEDICAL PUBLICATIONS
The Efficacy of Chemotherapy for Cancer
PDF Clinical Trial Publication U of A 2010
F.D.A. Approves Drug for Bone Marrow Disease
Absence of Mutagenic Effects of Sodium Dichloroacetate
Informational Guide:
DCA guide
© 2022 DCA WATCH
RECENT COMMENTS